Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 2376 to 2400 of 2529

TitleReference numberPublishedLast updated
Transvaginal laser therapy for urogenital atrophyHTG582
Transvaginal mesh repair of anterior or posterior vaginal wall prolapseHTG456
Transvenous obliteration for gastric varicesHTG658
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapyTA992
Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)TA976
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatmentsTA862
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapiesTA704
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)TA879
Trastuzumab deruxtecan for treating hormone receptor-positive HER2-low metastatic breast cancer after 2 or more endocrine treatments (terminated appraisal)TA1112
Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancerTA632
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxaneTA458
Trastuzumab for the treatment of HER2-positive metastatic gastric cancerTA208
TraumaQS166
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)TA945
Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplantTA640
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852
Trifluridine–tipiracil with bevacizumab for treating metastatic colorectal cancer after 2 systemic treatmentsTA1008
trublood-prostate for triaging and diagnosing people with prostate cancer symptomsMIB268
TuberculosisNG33
TuberculosisQS141
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisationMIB210
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerHTG719
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosisHTG648

Results per page

  1. 10
  2. 25
  3. 50
  4. All